Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study is performed to analyze various aspects of biofilms on ureteral stents in a longterm setting.
The study is performed to provide a better understanding of the influence of biofilms on ureteral stents on the entire spectrum of stent-associated morbidity in a longterm setting.
In addition, the trial is intended to give an overview of the incidence of complaints, the occurrence of complications and their economic aspects.
The influence of biofilms on the morbidity associated with longterm ureteral stenting is assessed.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Patients with longterm ureteral stent |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Stent examination, urinary analysis, USSQ questionnaire | Other |
|
| Measure | Description | Time Frame |
|---|---|---|
| Total biofilm mass on ureteral stents | Time of stent removal/change: three months (range 2-4 months) after last stent insertion/change | |
| Assessment of morbidity using the Ureteral Stent Symptom Questionnaire (USSQ) | Day of stent removal/change: three months (range 2-4 months) after last stent insertion/change |
| Measure | Description | Time Frame |
|---|---|---|
| Urine Culture | 2-6 months after stent insertion | |
| Number of bacteria on stent surface, if applicable number of bacteria on two indwelling stents | 2-6 months after stent insertion | |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Patients with longterm indwelling ureteral stent undergoing regular changes in an inpatient or outpatient setting at the department of urology of KSSG.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Patrick Betschart, Dr. med. | Department of Urology | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Urological Department, Cantonal Hospital of St. Gallen | Sankt Gallen | Switzerland |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Number of participants with treatment-related adverse events as assessed by CTCAE v4.0 |
| 2-6 months after stent insertion |
| Assessment of costs arising from complications | complications assessed by CTCAE v4.0 | 2-6 months after stent insertion |